2
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Training and clinical testing of artificial intelligence derived right atrial cardiovascular magnetic resonance measurements

      research-article
      1 , 1 , 2 , 3 , 1 , 4 , 1 , 4 , 1 , 1 , 1 , 1 , 4 , 5 , 1 , 1 , 2 , 6 , 6 , 1 , 6 , 6 , 2 , 5 , 7 , 7 , 1 , 1 , 2 , 8 , 1 , 2 , 6 , 8 , 1 , 2 ,
      Journal of Cardiovascular Magnetic Resonance
      BioMed Central
      Right atrial area, Cardiovascular magnetic resonance, Convolutional neural networks, Artificial intelligence, Deep learning training, Clinical testing, Repeatability assessment, Mortality prediction

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Background

          Right atrial (RA) area predicts mortality in patients with pulmonary hypertension, and is recommended by the European Society of Cardiology/European Respiratory Society pulmonary hypertension guidelines. The advent of deep learning may allow more reliable measurement of RA areas to improve clinical assessments. The aim of this study was to automate cardiovascular magnetic resonance (CMR) RA area measurements and evaluate the clinical utility by assessing repeatability, correlation with invasive haemodynamics and prognostic value.

          Methods

          A deep learning RA area CMR contouring model was trained in a multicentre cohort of 365 patients with pulmonary hypertension, left ventricular pathology and healthy subjects. Inter-study repeatability (intraclass correlation coefficient (ICC)) and agreement of contours (DICE similarity coefficient (DSC)) were assessed in a prospective cohort (n = 36). Clinical testing and mortality prediction was performed in n = 400 patients that were not used in the training nor prospective cohort, and the correlation of automatic and manual RA measurements with invasive haemodynamics assessed in n = 212/400. Radiologist quality control (QC) was performed in the ASPIRE registry, n = 3795 patients. The primary QC observer evaluated all the segmentations and recorded them as satisfactory, suboptimal or failure. A second QC observer analysed a random subcohort to assess QC agreement (n = 1018).

          Results

          All deep learning RA measurements showed higher interstudy repeatability (ICC 0.91 to 0.95) compared to manual RA measurements (1st observer ICC 0.82 to 0.88, 2nd observer ICC 0.88 to 0.91). DSC showed high agreement comparing automatic artificial intelligence and manual CMR readers. Maximal RA area mean and standard deviation (SD) DSC metric for observer 1 vs observer 2, automatic measurements vs observer 1 and automatic measurements vs observer 2 is 92.4 ± 3.5 cm 2, 91.2 ± 4.5 cm 2 and 93.2 ± 3.2 cm 2, respectively. Minimal RA area mean and SD DSC metric for observer 1 vs observer 2, automatic measurements vs observer 1 and automatic measurements vs observer 2 was 89.8 ± 3.9 cm 2, 87.0 ± 5.8 cm 2 and 91.8 ± 4.8 cm 2. Automatic RA area measurements all showed moderate correlation with invasive parameters (r = 0.45 to 0.66), manual (r = 0.36 to 0.57). Maximal RA area could accurately predict elevated mean RA pressure low and high-risk thresholds (area under the receiver operating characteristic curve artificial intelligence = 0.82/0.87 vs manual = 0.78/0.83), and predicted mortality similar to manual measurements, both p < 0.01. In the QC evaluation, artificial intelligence segmentations were suboptimal at 108/3795 and a low failure rate of 16/3795. In a subcohort (n = 1018), agreement by two QC observers was excellent, kappa 0.84.

          Conclusion

          Automatic artificial intelligence CMR derived RA size and function are accurate, have excellent repeatability, moderate associations with invasive haemodynamics and predict mortality.

          Supplementary Information

          The online version contains supplementary material available at 10.1186/s12968-022-00855-3.

          Related collections

          Most cited references39

          • Record: found
          • Abstract: found
          • Article: not found

          2015 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension: The Joint Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS): Endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC), International Society for Heart and Lung Transplantation (ISHLT).

          Guidelines summarize and evaluate all available evidence on a particular issue at the time of the writing process, with the aim of assisting health professionals in selecting the best management strategies for an individual patient with a given condition, taking into account the impact on outcome, as well as the risk-benefit ratio of particular diagnostic or therapeutic means. Guidelines and recommendations should help health professionals to make decisions in their daily practice. However, the final decisions concerning an individual patient must be made by the responsible health professional(s) in consultation with the patient and caregiver as appropriate.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            Survival in patients with primary pulmonary hypertension. Results from a national prospective registry.

            To characterize mortality in persons diagnosed with primary pulmonary hypertension and to investigate factors associated with survival. Registry with prospective follow-up. Thirty-two clinical centers in the United States participating in the Patient Registry for the Characterization of Primary Pulmonary Hypertension supported by the National Heart, Lung, and Blood Institute. Patients (194) diagnosed at clinical centers between 1 July 1981 and 31 December 1985 and followed through 8 August 1988. At diagnosis, measurements of hemodynamic variables, pulmonary function, and gas exchange variables were taken in addition to information on demographic variables, medical history, and life-style. Patients were followed for survival at 6-month intervals. The estimated median survival of these patients was 2.8 years (95% Cl, 1.9 to 3.7 years). Estimated single-year survival rates were as follows: at 1 year, 68% (Cl, 61% to 75%); at 3 years, 48% (Cl, 41% to 55%); and at 5 years, 34% (Cl, 24% to 44%). Variables associated with poor survival included a New York Heart Association (NYHA) functional class of III or IV, presence of Raynaud phenomenon, elevated mean right atrial pressure, elevated mean pulmonary artery pressure, decreased cardiac index, and decreased diffusing capacity for carbon monoxide (DLCO). Drug therapy at entry or discharge was not associated with survival duration. Mortality was most closely associated with right ventricular hemodynamic function and can be characterized by means of an equation using three variables: mean pulmonary artery pressure, mean right atrial pressure, and cardiac index. Such an equation, once validated prospectively, could be used as an adjunct in planning treatment strategies and allocating medical resources.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              Increased central venous pressure is associated with impaired renal function and mortality in a broad spectrum of patients with cardiovascular disease.

              We sought to investigate the relationship between increased central venous pressure (CVP), renal function, and mortality in a broad spectrum of cardiovascular patients. The pathophysiology of impaired renal function in cardiovascular disease is multifactorial. The relative importance of increased CVP has not been addressed previously. A total of 2,557 patients who underwent right heart catheterization in the University Medical Center Groningen, the Netherlands, between January 1, 1989, and December 31, 2006, were identified, and their data were extracted from electronic databases. Estimated glomerular filtration rate (eGFR) was assessed with the simplified modification of diet in renal disease formula. Mean age was 59 +/- 15 years, and 57% were men. Mean eGFR was 65 +/- 24 ml/min/1.73 m(2), with a cardiac index of 2.9 +/- 0.8 l/min/m(2) and CVP of 5.9 +/- 4.3 mm Hg. We found that CVP was associated with cardiac index (r = -0.259, p < 0.0001) and eGFR (r = -0.147, p < 0.0001). Also, cardiac index was associated with eGFR (r = 0.123, p < 0.0001). In multivariate analysis CVP remained associated with eGFR (r = -0.108, p < 0.0001). In a median follow-up time of 10.7 years, 741 (29%) patients died. We found that CVP was an independent predictor of reduced survival (hazard ratio: 1.03 per mm Hg increase, 95% confidence interval: 1.01 to 1.05, p = 0.0032). Increased CVP is associated with impaired renal function and independently related to all-cause mortality in a broad spectrum of patients with cardiovascular disease.
                Bookmark

                Author and article information

                Contributors
                a.j.swift@sheffield.ac.uk
                Journal
                J Cardiovasc Magn Reson
                J Cardiovasc Magn Reson
                Journal of Cardiovascular Magnetic Resonance
                BioMed Central (London )
                1097-6647
                1532-429X
                7 April 2022
                7 April 2022
                2022
                : 24
                : 25
                Affiliations
                [1 ]GRID grid.11835.3e, ISNI 0000 0004 1936 9262, Department of Infection, Immunity and Cardiovascular Disease, , University of Sheffield, ; Sheffield, UK
                [2 ]GRID grid.11835.3e, ISNI 0000 0004 1936 9262, INSIGNEO, Institute for In Silico Medicine, University of Sheffield, ; Sheffield, UK
                [3 ]GRID grid.8273.e, ISNI 0000 0001 1092 7967, Norwich Medical School, , University of East Anglia, ; Norwich, UK
                [4 ]GRID grid.31410.37, ISNI 0000 0000 9422 8284, Radiology Department, , Sheffield Teaching Hospitals NHS Foundation Trust, ; Sheffield, UK
                [5 ]GRID grid.11835.3e, ISNI 0000 0004 1936 9262, Department of Computer Science, , University of Sheffield, ; Sheffield, UK
                [6 ]GRID grid.416126.6, ISNI 0000 0004 0641 6031, Sheffield Pulmonary Vascular Disease Unit, , Royal Hallamshire Hospital, Sheffield Teaching Hospitals NHS Foundation Trust, ; Sheffield, UK
                [7 ]GRID grid.9909.9, ISNI 0000 0004 1936 8403, Multidisciplinary Cardiovascular Research Centre (MCRC) &, Biomedical Imaging Science Department, Leeds Institute of Cardiovascular and Metabolic Medicine, , University of Leeds, ; Clarendon Way, Leeds, UK
                [8 ]GRID grid.10419.3d, ISNI 0000000089452978, Division of Image Processing, Department of Radiology, , Leiden University Medical Center, ; Leiden, Netherlands
                Author information
                http://orcid.org/0000-0002-8772-409X
                Article
                855
                10.1186/s12968-022-00855-3
                8988415
                35387651
                5ff8ad37-8399-4bf7-831b-cd3537096cb2
                © The Author(s) 2022

                Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver ( http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.

                History
                : 15 September 2021
                : 19 March 2022
                Funding
                Funded by: FundRef http://dx.doi.org/10.13039/100004440, Wellcome Trust;
                Award ID: 205188/Z/16/Z
                Award Recipient :
                Funded by: NIHR AI Award
                Award ID: AI_AWARD01706
                Award Recipient :
                Categories
                Research
                Custom metadata
                © The Author(s) 2022

                Cardiovascular Medicine
                right atrial area,cardiovascular magnetic resonance,convolutional neural networks,artificial intelligence,deep learning training,clinical testing,repeatability assessment,mortality prediction

                Comments

                Comment on this article